Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Bu, L.-L
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
Anti-inflammatory properties
Furthermore, through gene expression analysis, we investigated the expression of several antioxidant enzymes in the liver
It is a byproduct of what is used in the medications recommended for thinning asthmatic mucus
/assets/images/provider/photos/2775905.jpeg)
